The effects of gaviscon and metoclopramide in gastroesophageal reflux in children
- PMID: 3016226
- DOI: 10.1097/00005176-198607000-00008
The effects of gaviscon and metoclopramide in gastroesophageal reflux in children
Abstract
Oral metoclopramide (0.5 mg/kg/24 h) and a liquid alginic acid-antacid compound were administered to infants and children with gastroesophageal reflux (GER) in a double-blind randomized controlled trial. The effect of medication was measured with 24-h intraesophageal pH monitoring. Neither metoclopramide nor the alginic acid-antacid compound decreased the frequency or duration of gastroesophageal reflux.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
